EPHESUS was a multicentre , double-blind clinical trial in which 6632 patients with acute myocardial infarction ( AMI ) complicated by LV systolic dysfunction ( LVSD ) were randomized to receive eplerenone ( n = 3319 ) or placebo ( n = 3313 ) .